发明授权
- 专利标题： Glycine transporter inhibiting substances
- 专利标题（中）： 甘氨酸转运蛋白抑制物质
-
申请号： US13823574申请日： 2011-09-16
-
公开(公告)号： US08729271B2公开(公告)日： 2014-05-20
- 发明人: Minoru Moriya , Akito Yasuhara , Kazunari Sakagami , Hiroshi Ohta , Kumi Abe , Shuji Yamamoto , Yuko Araki , Hiroki Urabe , Xiang-Min Sun
- 申请人： Minoru Moriya , Akito Yasuhara , Kazunari Sakagami , Hiroshi Ohta , Kumi Abe , Shuji Yamamoto , Yuko Araki , Hiroki Urabe , Xiang-Min Sun
- 申请人地址： JP Tokyo
- 专利权人： Taisho Pharmaceutical Co., Ltd
- 当前专利权人： Taisho Pharmaceutical Co., Ltd
- 当前专利权人地址： JP Tokyo
- 代理机构： Sughrue Mion, PLLC
- 优先权： JP2010-209184 20100917
- 国际申请： PCT/JP2011/071241 WO 20110916
- 国际公布： WO2012/036278 WO 20120322
- 主分类号： A01N43/40
- IPC分类号： A01N43/40 ; A61K31/44 ; A01N43/64 ; A61K31/41 ; C07D213/00 ; C07D401/00 ; C07D419/00
摘要：
The present invention aims to provide novel compounds of formula [I] or pharmaceutically acceptable salts thereof that are based on a glycine uptake inhibiting action and which are useful in the prevention or treatment of such diseases as schizophrenia, Alzheimer's disease, cognitive dysfunction, dementia, anxiety disorders (generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, social anxiety disorder, posttraumatic stress disorder, specific phobia, acute stress disorder, etc.), depression, drug addiction, spasm, tremor, pain, and sleep disorder:
公开/授权文献
- US20130184460A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES 公开/授权日：2013-07-18
信息查询
IPC分类:
